Diagnostic delays stem from uneven access to specialist testing, lack of reliable biomarkers, and symptom overlap with common mental health and attention disorders.

The U.S. In Vitro Diagnostics (IVD) and Laboratory-Developed Tests (LDT) market for autoimmune diseases is set to witness transformative growth over the next decade. Valued at USD 2.51 billion in 2023 ...

Please provide your email address to receive an email when new articles are posted on . Patients with narcolepsy have increased cardiovascular risks, according to researchers.. Participants who ...

When Katelynn O’Connell takes her lunch break at work, she follows a routine that sets her apart from other employees. Each day at noon, she unfolds a cot in her small office, turns on a white noise ...

Drug developers from around the world rang in a new era of sleep medicine Monday, as data from a series of clinical trials showed narcolepsy can be effectively treated by amplifying a specific brain ...

Takeda Pharmaceutical Co.’s experimental narcolepsy drug significantly improved outcome for patients in late-stage clinical trials, and could become the first treatment to target the root cause of the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Positive late-stage trial ...

A hormone produced by the brain, orexin, may play a central role in the functioning of the brain’s glymphatic system, which clears waste, according to a new study from the University of Oulu.

Because of narcolepsy, Green Bay Packers defensive tackle Nazir Stackhouse sometimes fell asleep during games at Georgia. With different medication, “Big Sleepy” is in position to challenge for a ...

Takeda Pharmaceutical Co. Ltd.’s dual phase III victories in narcolepsy type 1 (NT1) with oral orexin receptor 2 (OX2R)-selective agonist oveporexton (also known as TAK-861) had Wall Street mulling ...

One cheerleader is rewriting what determination looks like by pushing boundaries on the mat while managing a chronic sleep disorder Tereza Shkurtaj is a writer-reporter at PEOPLE. She has been working ...